<DOC>
	<DOC>NCT02056145</DOC>
	<brief_summary>Evaluation of the combination of lateral femoral cutaneous nerve "single shot" and femoral nerve "single shot" block as effective and safe alternative postoperative analgesic technique after hip replacement surgery.</brief_summary>
	<brief_title>Ultrasound Guided Lateral Femoral Cutaneous Block (LFCNB) And Femoral Nerve Block (FNB) For Postoperative Pain Control After Hip Surgery</brief_title>
	<detailed_description>Clinical evaluation via a prospective, double-blinded, randomized clinical trial, whether ultrasound-guided single femoral block and lateral femoral cutaneous nerve blocks with 20 en 10 cc bupivacaine 0.25% respectively vs. the only ultrasound-guided single femoral block with 20 cc bupivacaine 0.25%, given just prior to elective hip surgery procedure, is effective in reducing acute postoperative pain (VAS scores) and postoperative opiate consumption.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Primary hip arthroplasty with posterolateral approach. Known allergy to levobupivacaine and / or piritramide Known neurological disorders or peripheral neuropathies Existing drug or alcohol abuse Chronic use of pain medication (&gt; started 3 months ago) not related to the hip suffering Coagulopathy (international normalized ratio) &gt; 1.4 Thrombocytopenia &lt;70,000 platelets, Dementia Pregnancy Local infection hip Hepatic and / or renal impairment BMI&gt; 45.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>